Westover Capital Advisors’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,835
| Closed | -$844K | – | 238 |
|
|
2024
Q3 | $844K | Sell |
10,835
-352
| -3% | -$27.4K | 0.16% | 108 |
|
|
2024
Q2 | $872K | Buy |
11,187
+2,620
| +31% | +$204K | 0.22% | 94 |
|
|
2024
Q1 | $580K | Buy |
8,567
+4,321
| +102% | +$293K | 0.17% | 104 |
|
|
2023
Q4 | $286K | Sell |
4,246
-15
| -0.4% | -$1.01K | 0.09% | 145 |
|
|
2023
Q3 | $289K | Sell |
4,261
-50
| -1% | -$3.39K | 0.1% | 139 |
|
|
2023
Q2 | $309K | Sell |
4,311
-17
| -0.4% | -$1.22K | 0.11% | 134 |
|
|
2023
Q1 | $300K | Hold |
4,328
| – | – | 0.11% | 134 |
|
|
2022
Q4 | $293K | Buy |
4,328
+21
| +0.5% | +$1.42K | 0.12% | 122 |
|
|
2022
Q3 | $236K | Sell |
4,307
-1,092
| -20% | -$59.8K | 0.09% | 141 |
|
|
2022
Q2 | $357K | Buy |
+5,399
| New | +$357K | 0.13% | 113 |
|
|
2021
Q4 | – | Sell |
-4,979
| Closed | -$299K | – | 178 |
|
|
2021
Q3 | $299K | Buy |
4,979
+226
| +5% | +$13.6K | 0.09% | 140 |
|
|
2021
Q2 | $285K | Sell |
4,753
-132
| -3% | -$7.92K | 0.09% | 146 |
|
|
2021
Q1 | $243K | Buy |
4,885
+275
| +6% | +$13.7K | 0.08% | 152 |
|
|
2020
Q4 | $230K | Sell |
4,610
-452
| -9% | -$22.6K | 0.08% | 135 |
|
|
2020
Q3 | $277K | Buy |
5,062
+452
| +10% | +$24.7K | 0.11% | 109 |
|
|
2020
Q2 | $244K | Hold |
4,610
| – | – | 0.11% | 100 |
|
|
2020
Q1 | $206K | Hold |
4,610
| – | – | 0.11% | 111 |
|
|
2019
Q4 | $230K | Hold |
4,610
| – | – | 0.1% | 127 |
|
|
2019
Q3 | $205K | Buy |
+4,610
| New | +$205K | 0.1% | 132 |
|